日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma

卡非佐米、来那度胺和地塞米松联合移植治疗新诊断的多发性骨髓瘤

Jasielec, Jagoda K; Kubicki, Tadeusz; Raje, Noopur; Vij, Ravi; Reece, Donna; Berdeja, Jesus; Derman, Benjamin A; Rosenbaum, Cara A; Richardson, Paul; Gurbuxani, Sandeep; Major, Sarah; Wolfe, Brittany; Stefka, Andrew T; Stephens, Leonor; Tinari, Kathryn M; Hycner, Tyler; Rojek, Alexandra E; Dytfeld, Dominik; Griffith, Kent A; Zimmerman, Todd M; Jakubowiak, Andrzej J

Phase 1 study of selinexor plus carfilzomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma

塞利尼索联合卡非佐米和地塞米松治疗复发/难治性多发性骨髓瘤的I期研究

Jakubowiak, Andrzej J; Jasielec, Jagoda K; Rosenbaum, Cara A; Cole, Craig E; Chari, Ajai; Mikhael, Joseph; Nam, Jennifer; McIver, Amanda; Severson, Erica; Stephens, Leonor A; Tinari, Kathryn; Rosebeck, Shaun; Zimmerman, Todd M; Hycner, Tyler; Turowski, Agata; Karrison, Theodore; Zonder, Jeffrey A